View post:
Interim report for Q1 2022
Author Archives: Fredricko
Novozymes delivers strong 2022 Q1 results and raises full-year financial guidance
BlueSphere Bio Appoints Robert Keefe, Ph.D. as Chief Development Officer
See the rest here:
BlueSphere Bio Appoints Robert Keefe, Ph.D. as Chief Development Officer
Petros Pharmaceuticals, Inc. Engages Massachusetts General Hospital in a Sponsored Research Agreement for Tissue-Specific Oxygenation Sensor…
Tiziana Life Sciences to participate in a Fireside Chat At the B. Riley Securities 2022 Virtual Neuro & Ophthalmology Conference
Sanofi: Information concerning the total number of voting rights and shares – March 2022
Eurobio Scientific partners with Dr. Nino Guy Cassuto for the development of a new PCR test for male fertility
Collegium to Host Conference Call to Discuss First Quarter 2022 Financial Results
Galapagos announces appointment of Dr. Paul Stoffels as Chairman of the board
Here is the original post:
Galapagos announces appointment of Dr. Paul Stoffels as Chairman of the board
Paratek Pharmaceuticals to Report First Quarter 2022 Financial Results on May 4, 2022
RZ358 Phase 2b (RIZE Study) Topline Data to be Unveiled at Pediatric Endocrine Society Annual Meeting on May 1, 2022
Berkeley Lights to Report First Quarter 2022 Financial Results on May 9, 2022
Continue reading here:
Berkeley Lights to Report First Quarter 2022 Financial Results on May 9, 2022
BioSyent to Present at 2022 Bloom Burton & Co. Healthcare Investor Conference
Continue reading here:
BioSyent to Present at 2022 Bloom Burton & Co. Healthcare Investor Conference
SCYNEXIS Announces Closing of $45 Million Public Offering of Common Stock, Pre-Funded Warrants and Warrants
Acerus Announces Completion of Share Consolidation
Read the original here:
Acerus Announces Completion of Share Consolidation
Basilea announces licensing of a novel first-in-class antifungal program from Fox Chase Chemical Diversity Center
Vistin Pharma ASA: First quarter 2022 financial results
Continue reading here:
Vistin Pharma ASA: First quarter 2022 financial results
Saniona Changes Date of Annual Report for 2021
Excerpt from:
Saniona Changes Date of Annual Report for 2021